miércoles, 3 de abril de 2024

Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00629-1/abstract?utm_campaign=update-laninf&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laninf&_hsenc=p2ANqtz-92sTPMzT42BoW_Xnv2aoe2NpHFJb9Ba8DAp8rK0R34XsaovbhVaMkyc-yblZUpuzuRg1_bDZThRNO5AOLBMtgmjeNyzw&_hsmi=300878298&utm_content=300845929&utm_source=hs_email

No hay comentarios: